Cargando…
Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
BACKGROUND: It is recommended postoperative adjuvant chemotherapy for all rectal cancers undergoing neo-chemoradiotherapy regardless of the final yield pathology. However, the role of adjuvant chemotherapy in pathological complete response (pCR) remains controversial. We aimed to identify the necess...
Autores principales: | Hu, Xiang, Li, Ya-Qi, Ma, Xiao-ji, Zhang, Long, Cai, San-Jun, Peng, Jun-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515679/ https://www.ncbi.nlm.nih.gov/pubmed/31114447 http://dx.doi.org/10.1186/s12935-019-0851-9 |
Ejemplares similares
-
Clinical significance of adjuvant chemotherapy for pathological
complete response rectal cancer patients with acellular mucin pools after
neoadjuvant chemoradiotherapy
por: Chen, Mian, et al.
Publicado: (2023) -
Draft Genome Sequence of Streptomyces rapamycinicus Strain NRRL 5491, the Producer of the Immunosuppressant Rapamycin
por: Baranasic, Damir, et al.
Publicado: (2013) -
Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
por: Jo, Hee-Geun, et al.
Publicado: (2022) -
Technical Specification No, 122: Specification for multicore cables used in control systems (I - 5491/MPS)
Publicado: (1968) -
Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
por: Allen, D. C., et al.
Publicado: (1999)